Transforming growth factor β expression during an inner ear immune response

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 1, 2006, Pages 81-88

  Satoh, Hitoshi ^a,b,c   Billings, Peter ^a,b   Firestein, Gary S ^a   Harris, Jeffrey P ^a,b   Keithley, Elizabeth M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Cochlear inflammation; Inner ear immunity; Transforming growth factor

Indexed keywords

LATENCY ASSOCIATED PEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASILAR MEMBRANE; CELL INFILTRATION; COCHLEA; CONTROLLED STUDY; ENDOLYMPHATIC SAC; FEMALE; FIBROGENESIS; IMMUNE RESPONSE; IMMUNOREACTIVITY; INNER EAR; MESOTHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 31144432878     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940611500112     Document Type: Article

References (32)

1. Rauch SD, Herrmann BS, Davis LA, Nadol JB Jr. Nucleus 22 cochlear implantation results in postmeningitic deafness. Laryngoscope 1997;107:1606-9.
2. Axon PR, Temple RH, Saeed SR, Ramsden RT. Cochlear ossification after meningitis. Am J Otol 1998;19:724-9.
3. Hoistad DL, Schachern PA, Paparella MM. Autoimmune sensorineural hearing loss: a human temporal bone study. Am J Otolaryngol 1998;19:33-9.
4. Keithley EM, Chen MC, Linthicum F. Clinical diagnoses associated with histologic findings of fibrotic tissue and new bone in the inner ear. Laryngoscope 1998;108:87-91.
5. Harris JP. Immunology of the inner ear: evidence of local antibody production. Ann Otol Rhinol Laryngol 1984;93:157-62.
6. Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM. Tumor necrosis factor-α, an initiator, and Etanercept, an inhibitor of cochlear inflammation. Laryngoscope 2002;112:1627-34.
7. [Erratum in Laryngoscope 2003;113:291.]
8. Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM. Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. J Assoc Res Otolaryngol 2003; 4:139-47.
9. Ma CL, Billings P, Harris JP, Keithley EM. Characterization of an experimentally induced inner ear immune response. Laryngoscope 2000;110:451-6.
10. Wahl SM. Transforming growth factor β: the good, the bad, and the ugly. J Exp Med 1994;180:1587-90.
11. Chen W, Wahl SM. Manipulation of TGF-β to control autoimmune and chronic inflammatory diseases. Microbes Infect 1999;1:1367-80.
12. Sime PJ, O'Reilly KM. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol 2001;99:308-19.
13. Murphy-Ullrich JE, Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 2000;11:59-69.
14. Yeo SW, Ryan AF. Transforming growth factor-beta (TGF-β) mRN A expression in the rat cochlea during experimental immune labyrinthitis. In: Mogi G, Veldman J, Harris JP, eds. Immunology in otolaryngology. Amstelveen: the Netherlands, Kugler, 1994:181-8.
15. Barcellos-Hoff MH, Derynck R, Tsang ML, Weatherbee JA. Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest 1994;93:892-9.
16. Ehrhart EJ, Segarini P, Tsang ML, Carroll AG, Barcellos-Hoff MH. Latent transforming growth factor β1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation. FASEB J 1997;11:991-1002.
17. Ewan KB, Shyamala G, Ravani SA, et al. Latent transforming growth factor-β activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol 2002;160:2081-93.
18. Rappolee DA, Werb Z. Macrophage-derived growth factors. Curr Top Microbiol Immunol 1992;181:87-140.
19. Stein M, Keshav S. The versatility of macrophages. Clin Exp Allergy 1992;22:19-27.
20. Derynck R, Jarrett JA, Chen EY, et al. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-5.
21. Okada F, Yamaguchi K, Ichihara A, Nakamura T. One of two subunits of masking protein in latent TGF-beta is a part of pro-TGF-beta. FEBS Lett 1989;242:240-4.
22. Gentry LE, Nash BW. The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor. Biochemistry 1990;29:6851-7.
23. Takahashi M, Harris JP. Analysis of immunocompetent cells following inner ear immunostimulation. Laryngoscope 1988;98:1133-8.
24. Iguchi H, Yamane H, Konishi K, et al. Asialo GM1-positive cells in mouse cochlea. Acta Otolaryngol Suppl (Stockh) 1997(suppl 528):6-9.
25. Kuwahara M, Kagan E. The mesothelial cell and its role in asbestos-induced pleural injury. Int J Exp Pathol 1995;76:163-70.
26. Kimura RS. The ultrastructure of the organ of Corti. Int Rev Cytol 1975;42:173-222.
27. Angelborg C. Distribution of macromolecular tracer particles (Thorotrast®) in the cochlea. An electron microscopic study in guinea pig. Part I. The organ of Corti, the basilar membrane and the tympanic covering layer. Acta Otolaryngol Suppl (Stockh) 1974(suppl 319):19-41.
28. Keithley EM, Ryan AF, Woolf NK. Fibronectin-like immunoreactivity of the basilar membrane of young and aged rats. J Comp Neurol 1993;327:612-7.
29. Keithley EM, Tian Q, Robins-Browne R. Fibronectin-like immunoreactivity of the basilar membrane of celloidin-embedded human temporal bone sections. Acta Otolaryngol (Stockh) 1994;114:613-9.
30. Yagi M, Magal E, Sheng Z, Ang KA, Raphael Y. Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. Hum Gene Ther 1999;10:813-23.
31. Kawamoto K, Yagi M, Stover T, Kanzaki S, Raphael Y. Hearing and hair cells are protected by adenoviral gene therapy with TGF-β1 and GDNF. Mol Ther 2003;7:484-92.
32. Yeo SW, Gottschlich S, Harris JP, Keithley EM. Antigen diffusion from the perilymphatic space of the cochlea. Laryngoscope 1995;105:623-8.